124 related articles for article (PubMed ID: 28816549)
1. Implications of Bcl-2 and its interplay with other molecules and signaling pathways in prostate cancer progression.
Kim JH; Lee H; Shin EA; Kim DH; Choi JB; Kim SH
Expert Opin Ther Targets; 2017 Sep; 21(9):911-920. PubMed ID: 28816549
[TBL] [Abstract][Full Text] [Related]
2. Bad expression influences time to androgen escape in prostate cancer.
Teo K; Gemmell L; Mukherjee R; Traynor P; Edwards J
BJU Int; 2007 Sep; 100(3):691-6. PubMed ID: 17542986
[TBL] [Abstract][Full Text] [Related]
3. Exosomes Promote the Transition of Androgen-Dependent Prostate Cancer Cells into Androgen-Independent Manner Through Up-Regulating the Heme Oxygenase-1.
Zhang Y; Chen B; Xu N; Xu P; Lin W; Liu C; Huang P
Int J Nanomedicine; 2021; 16():315-327. PubMed ID: 33469288
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
Pang B; Zhang H; Wang J; Chen WZ; Li SH; Shi QG; Liang RX; Xie BX; Wu RQ; Qian XL; Yu L; Li QM; Huang CF; Zhou JG
Prostate; 2009 Aug; 69(11):1176-87. PubMed ID: 19415690
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of Bcl-2 is required for the progression of prostate cancer cells from an androgen-dependent to an androgen-independent growth stage.
Lin Y; Fukuchi J; Hiipakka RA; Kokontis JM; Xiang J
Cell Res; 2007 Jun; 17(6):531-6. PubMed ID: 17404601
[TBL] [Abstract][Full Text] [Related]
6. The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer.
Fizazi K; Martinez LA; Sikes CR; Johnston DA; Stephens LC; McDonnell TJ; Logothetis CJ; Trapman J; Pisters LL; Ordoñez NG; Troncoso P; Navone NM
Clin Cancer Res; 2002 Mar; 8(3):775-81. PubMed ID: 11895908
[TBL] [Abstract][Full Text] [Related]
7. BCL-2 in prostate cancer: a minireview.
Catz SD; Johnson JL
Apoptosis; 2003 Jan; 8(1):29-37. PubMed ID: 12510149
[TBL] [Abstract][Full Text] [Related]
8. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
Shi Y; Chatterjee SJ; Brands FH; Shi SR; Pootrakul L; Taylor CR; Datar R; Cote RJ
BJU Int; 2006 Jan; 97(1):170-8. PubMed ID: 16336351
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer.
Abd Wahab NA; Lajis NH; Abas F; Othman I; Naidu R
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32131560
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.
Jia RP; Xu LW; Su Q; Zhao JH; Li WC; Wang F; Xu Z
Asian J Androl; 2008 Sep; 10(5):758-64. PubMed ID: 18645679
[TBL] [Abstract][Full Text] [Related]
11. Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells.
Huang H; Zegarra-Moro OL; Benson D; Tindall DJ
Oncogene; 2004 Mar; 23(12):2161-76. PubMed ID: 14676836
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of miR-200b-3p by low p73 contributes to the androgen-independence of prostate cancer cells.
He M; Liu Y; Deng X; Qi S; Sun X; Liu G; Liu Y; Liu Y; Zhao M
Prostate; 2013 Jul; 73(10):1048-56. PubMed ID: 23389960
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of ADAM9 by N-α-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer.
Lin YW; Wen YC; Chu CY; Tung MC; Yang YC; Hua KT; Pan KF; Hsiao M; Lee WJ; Chien MH
Cell Death Dis; 2020 Jul; 11(7):591. PubMed ID: 32719332
[TBL] [Abstract][Full Text] [Related]
14. [Screening of membrane antigen differentially expressed in androgen-dependent prostate cancer and androgen-independent prostate cancer].
Zhang X; Tang Z; Qi L; Chen H; Luo Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):817-23. PubMed ID: 22954909
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells.
MacManus CF; Pettigrew J; Seaton A; Wilson C; Maxwell PJ; Berlingeri S; Purcell C; McGurk M; Johnston PG; Waugh DJ
Mol Cancer Res; 2007 Jul; 5(7):737-48. PubMed ID: 17606477
[TBL] [Abstract][Full Text] [Related]
16. Antisense Bcl-2 oligodeoxynucleotides inhibit progression to androgen-independence after castration in the Shionogi tumor model.
Miyake H; Tolcher A; Gleave ME
Cancer Res; 1999 Aug; 59(16):4030-4. PubMed ID: 10463603
[TBL] [Abstract][Full Text] [Related]
17. [Literature-mining and bioinformatic analysis of androgen-independent prostate cancer-specific genes].
Li TQ; Feng CQ; Zou YG; Shi R; Liang S; Mao XM
Zhonghua Nan Ke Xue; 2009 Dec; 15(12):1102-7. PubMed ID: 20180422
[TBL] [Abstract][Full Text] [Related]
18. Gene microarray assessment of multiple genes and signal pathways involved in androgen-dependent prostate cancer becoming androgen independent.
Liu JB; Dai CM; Su XY; Cao L; Qin R; Kong QB
Asian Pac J Cancer Prev; 2014; 15(22):9791-5. PubMed ID: 25520106
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
20. Cellular growth factors as prospective therapeutic targets for combination therapy in androgen independent prostate cancer (AIPC).
Jonnalagadda B; Arockiasamy S; Krishnamoorthy S
Life Sci; 2020 Oct; 259():118208. PubMed ID: 32763294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
